Oklahoma’s ‘Precedent-Setting’ Suit Puts Opioid Drugmakers On Trial
All eyes were on Oklahoma last week, when the first case in a flood of litigation against opioid drug manufacturers began Tuesday.
June 3, 2019
Heart Drug Spotlights Troubling Trends In Drug Marketing
Headlines proclaimed a potential game changer in treating cardiovascular disease—Vascepa—and company shares quickly soared, but the study behind the claim remains a mystery.
November 7, 2018
New Opioid Approved by FDA, Mere Days After Trump Signs Opioid Bill
On October 24th, President Trump signed a package of bills designed to confront and combat the nation’s opioid epidemic. On November 2nd, the FDA approved Dsuvia.
November 7, 2018
Large Number of Influencers on the “Health Care 50” are in Biopharma
Of the fifty most influential people innovating healthcare named by Time Magazine, those with ties to biopharma make up a large percentage.
October 24, 2018